<document xmlns="http://cnx.rice.edu/cnxml">
  <title>Expectorants an Mucolytics</title>
  <metadata xmlns:md="http://cnx.rice.edu/mdml">
    <md:title>Expectorants an Mucolytics</md:title>
    <md:content-id>m00398</md:content-id>
    <md:uuid>62c1c747-6b54-4e4d-a469-2baa5183f785</md:uuid>
  </metadata>
  <content>
<section class="learning-objectives" id="sect-00001">
<title>Learning Outcomes</title>
<para id="para-00001">By the end of this section, you will be able to:</para>
<list id="list-00001">
<item>Identify the characteristics of expectorant and mucolytic drugs used to treat respiratory disorders.</item>
<item>Explain the indications, actions, adverse reactions, and interactions of expectorant and mucolytic drugs used to treat respiratory disorders.</item>
<item>Describe nursing implications of expectorant and mucolytic drugs used to treat respiratory disorders.</item>
<item>Explain the client education related to expectorant and mucolytic drugs used to treat respiratory disorders.</item>
</list>
</section>
<section id="sect-00002">
<title>Expectorants</title>
<para id="para-00002"><term id="term-00001">Expectorants</term> are a class of drugs that help to clear mucus from the airways when coughing. Expectorants can be stand-alone drugs or can be a part of combination cold and flu preparations. Expectorants do not suppress the cough like antitussives do, so they should only be used with productive coughs when it is necessary to loosen and clear mucus. Expectorants work by lubricating the airways, stimulating the cough reflex, and decreasing mucus viscosity so that it is easier to expel (Cleveland Clinic, 2021).</para>
<section id="sect-00003">
<title>Guaifenesin</title>
<para id="para-00003"><term class="no-emphasis" id="term-00002">Guaifenesin</term> is a common expectorant and is available over the counter without a prescription. It increases production of respiratory tract fluids to help liquefy mucus and make it easier to expel.</para>
<section id="sect-00004">
<title>Adverse Effects and Contraindications</title>
<para id="para-00004">Guaifenesin does not cause many adverse effects, but dizziness, headache, nausea, and vomiting may occur.</para>
<para id="para-00005"><link target-id="table-00001" document="m00398"/> is a drug prototype table for expectorants featuring guaifenesin. It lists drug class, mechanism of action, adult and <term class="no-emphasis" id="term-00003">pediatric dosage</term>, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00001">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Drug Class</span></emphasis><newline count="1"/>
Expectorant<newline count="1"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline count="1"/>
Increases production of respiratory tract fluids to liquefy mucus</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline count="1"/>
200–400 mg orally every 4 hours. <newline count="1"/>
<emphasis effect="italics">Extended-release tablets:</emphasis> 600–1200 mg orally every 12 hours. <newline count="1"/>
Maximum dose: 2400 mg daily.</entry>
</row>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Indications</emphasis></span><newline count="1"/>
Productive coughs where there is a need to clear the airway of mucus<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline count="1"/>
Thinner mucus that is easy to cough up and expel</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Interactions</emphasis></span><newline count="1"/>
Cimetidine<newline/>
Naltrexone <newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline count="1"/>
No significant interactions</entry>
</row>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Headache<newline/>
Dizziness<newline/>
Nausea <newline/>
Vomiting<newline/>
Urticaria</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
Hypersensitivity<newline/>
Children under age 12 (extended-release preparations)<newline count="2"/>
Caution: <newline count="1"/>
Pregnancy</entry>
</row>
</tbody>
</tgroup>
<caption>Drug Prototype Table: Guaifenesin<newline/>
(source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
</section>
</section>
</section>
<section id="sect-00005">
<title>Mucolytics</title>
<para id="para-00006"><term id="term-00004">Mucolytics</term> also help clients to clear mucus from the airway. They differ from expectorants in that they are used to help high-risk respiratory clients cough up thick, tenacious mucus. Mucolytics directly break down the structure of mucus by breaking its protein bonds, helping to reduce the thickness and stickiness of mucus. Clients with tracheostomies often benefit from mucolytics. Mucolytics are also sometimes used to clear the airway in preparation for a bronchoscopy.</para>
<section id="sect-00006">
<title>Acetylcysteine</title>
<para id="para-00007">Acetylcysteine is used to help clients clear thick, tenacious mucus from the airways. It is often used in clients with pneumonia, bronchitis, <term id="term-00005">cystic fibrosis</term>, and emphysema. It can also be used prior to bronchial studies, such as bronchoscopy, to help clear the airway, and is also used as routine tracheostomy care. To manage respiratory symptoms the medication is inhaled. Acetylcysteine is also administered orally or intravenously as the antidote for acetaminophen toxicity.</para>
<para id="para-00008">Side effects include tachycardia, nausea, and vomiting. Acetylcysteine is contraindicated in clients with hypersensitivity to it or those with peptic ulcer disease.</para>
</section>
<section id="sect-00007">
<title>Dornase Alfa</title>
<para id="para-00009">Dornase alfa is another mucolytic used most often to lower the number of lung infections and help lung function in cystic fibrosis. Dornase alfa acts like an enzyme naturally found in the lungs to help thin out thick, sticky mucus. Removing mucus in these clients helps to reduce the number of infections that they may have by reducing the potential breeding ground for bacteria.</para>
<para id="para-00010">Donase alfa can cause voice changes, hoarseness, and sore throat. It is contraindicated in those with hypersensitivity to the drug or to Chinese hamster ovary cell products used in the pharmaceutical industry.</para>
<para id="para-00011"><link target-id="table-00002" document="m00397"/> lists common mucolytics and typical routes and dosing for adult clients.</para>
<table class="vertically-tight" id="table-00002">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Drug</span></emphasis></entry>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Routes and Dosage Ranges</span></emphasis></entry>
</row>
<row>
<entry valign="top" align="center"><term class="no-emphasis" id="term-00006">Acetylcysteine</term><newline/>
(<term class="no-emphasis" id="term-00007">Mucomyst</term>)</entry>
<entry valign="top" align="left"><emphasis effect="italics">For removal of secretions in clients with cystic fibrosis, bronchitis, and other respiratory disorders:</emphasis> 1–2 mL of 10%–20% solution inhalant instilled into trachea as often as every hour. <newline/>
<emphasis effect="italics">Prior to diagnostic studies:</emphasis> 2–3 administrations of 1–2 mL of 20% solution inhalant or 2–4 mL of 10% solution inhalant prior to procedure.<newline/>
<emphasis effect="italics">For routine tracheostomy care:</emphasis> 1–2 mL of 10%–20% solution inhalant by direct instillation into tracheostomy every 1–4 hours.</entry>
</row>
<row>
<entry valign="top" align="center"><term class="no-emphasis" id="term-00008">Dornase alfa</term><newline/>
(<term class="no-emphasis" id="term-00009">Pulmozyme</term>)</entry>
<entry valign="top" align="left">2.5 mg of inhalant in nebulizer once per day.</entry>
</row>
</tbody>
</tgroup>
<caption>Drug Emphasis Table: Mucolytics<newline/>
(source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
<section id="sect-00008">
<title>Adverse Effects and Contraindications</title>
<para id="para-00012">Mucolytics can cause tachycardia, nausea, and vomiting. Some clients may experience voice changes, hoarseness, and sore throat. Clients with hypersensitivity to mucolytics and those with peptic ulcer disease should avoid these drugs.</para>
<para id="para-00013"><link target-id="table-00003" document="m00397"/> is a drug prototype table for mucolytics featuring acetylcysteine. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00003">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline count="1"/>
Mucolytic<newline count="1"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline count="1"/>
Reduces viscosity of pulmonary secretions</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline count="1"/>
<emphasis effect="italics">For removal of secretions in clients with cystic fibrosis, bronchitis, and other respiratory disorders:</emphasis> 1–2 mL of 10%–20% solution inhalant instilled into trachea as often as every hour. <newline/>
<emphasis effect="italics">Prior to diagnostic studies:</emphasis> 2–3 administrations of 1–2 mL of 20% solution inhalant or 2–4 mL of 10% solution inhalant prior to procedure.<newline/>
<emphasis effect="italics">Routine tracheostomy care:</emphasis> 1–2 mL of 10%–20% solution inhalant by direct instillation into tracheostomy every 1–4 hours.</entry>
</row>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Indications</emphasis></span><newline count="1"/>
Adjunctive therapy for pneumonia, bronchitis, and cystic fibrosis<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline count="1"/>
Thins pulmonary secretions and allows for easier clearance</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Interactions</emphasis></span><newline count="1"/>
Activated charcoal<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline count="1"/>
No significant interactions</entry>
</row>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Fever<newline/>
Tachycardia<newline/>
Nausea<newline/>
Vomiting<newline/>
Pharyngitis<newline/>
Bronchospasm<newline/>
Dyspnea</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline count="1"/>
Hypersensitivity<newline/>
Peptic ulcer disease<newline count="2"/>
Caution: <newline count="1"/>
Older adults with debilitation or severe respiratory insufficiency <newline count="1"/>
Asthma (IV form)</entry>
</row>
</tbody>
</tgroup>
<caption>Drug Prototype Table: Acetylcysteine<newline/>
(source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
<note class="link-to-learning" id="note-00001">
<title><emphasis effect="bold">Respiratory Therapy Zone</emphasis></title>
<media alt="atoms_isotopes">
<iframe width="560" height="315" src="https://openstax.org/r/mucolytic"/>
</media>
<para id="para-00014">This video from Respiratory Therapy Zone discusses the mucolytic agent acetylcysteine.</para>
</note>
<note class="safety-alert" id="note-00002">
<title><emphasis effect="bold">Mucolytics</emphasis></title>
<para id="para-00015">Because acetylcysteine commonly causes vomiting, it should be strictly avoided in client with peptic ulcer disease, esophageal varices, and <term id="term-00010">Mallory-Weis tears</term>.</para>
</note>
</section>
</section>
</section>
<section id="sect-00009">
<title>Nursing Implications</title>
<para id="para-00016">The nurse should do the following for the clients who are taking expectorants and mucolytics:</para>
<list list-type="bulleted" id="list-00002">
<item>Prior to administering, assess the client’s medical history, current drug list, and allergies for potential interactions and contraindications.</item>
<item>Assess the client’s respiratory status for signs of respiratory distress that indicate the need for additional evaluation and treatment. Also, identify the underlying reason for the cough to ensure the client is receiving the appropriate treatment.</item>
<item>Assess the client’s cough including the frequency and amount and type of sputum.</item>
<item>Educate the client on adverse effects of expectorants including headache, dizziness, nausea, and vomiting.</item>
<item>Educate the client on adverse effects of mucolytics including fever, tachycardia, and pharyngitis.</item>
<item>Monitor vital signs for tachycardia or fever for clients taking mucolytics.</item>
<item>Clients receiving acetylcysteine should be monitored closely for bronchospasm, especially if they have asthma, because they are at higher risk for bronchospasm.</item>
<item>Instruct the client on medication indications, dose, and when to call the healthcare provider. See below for client teaching guidelines.</item>
</list>
<note class="client-teaching" id="note-00003">
<para id="para-00017"><emphasis effect="bold">The client taking an expectorant or mucolytic should:</emphasis></para>
<list list-type="bulleted" id="list-00003">
<item>Take the drugs as prescribed and only for the time indicated.</item>
<item>Be sure to drink fluids to help loosen secretions.</item>
<item>Increase deep breathing exercises to assist with secretion movement.</item>
<item>Report any adverse effects.</item>
<item>Notify the health care provider if symptoms last longer than one week, become worse, or are accompanied by other symptoms.</item>
</list>
</note>
</section>
<section id="sect-00010">
<title>Chapter Summary</title>
<para id="para-00018">This chapter discussed various upper respiratory medications including antihistamines, decongestants, antitussives, expectorants, and mucolytics. Many of these medications are available over the counter and are widely used by clients. It is important to understand the appropriate use for each of these drugs and how they assist clients with respiratory disorders. Providing appropriate client education for these medications is crucial to ensure safe use and avoidance of adverse effects, especially because many of these medications come in combination products. The nurse should remind clients to check the labels of medications that they are taking to avoid ingesting too much of a particular medication.</para>
</section>
<section class="review-questions" id="sect-00011">
<title>Review Questions</title>
<exercise id="exer-00001"><problem id="prob-00001"><para id="para-00019"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec01_RQ1"/></para></problem></exercise>
<exercise id="exer-00002"><problem id="prob-00002"><para id="para-00020"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec03_RQ2"/></para></problem></exercise>
<exercise id="exer-00003"><problem id="prob-00003"><para id="para-00021"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec03_RQ3"/></para></problem></exercise>
<exercise id="exer-00004"><problem id="prob-00004"><para id="para-00022"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec01_RQ4"/></para></problem></exercise>
<exercise id="exer-00005"><problem id="prob-00005"><para id="para-00023"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec02_RQ5"/></para></problem></exercise>
<exercise id="exer-00006"><problem id="prob-00006"><para id="para-00024"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec02_RQ6"/></para></problem></exercise>
<exercise id="exer-00007"><problem id="prob-00007"><para id="para-00025"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec01_RQ7"/></para></problem></exercise>
<exercise id="exer-00008"><problem id="prob-00008"><para id="para-00026"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec01_RQ8"/></para></problem></exercise>
<exercise id="exer-00009"><problem id="prob-00009"><para id="para-00027"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec01_RQ9"/></para></problem></exercise>
<exercise id="exer-00010"><problem id="prob-00010"><para id="para-00028"><link class="os-embed" url="#exercise/PHAR_Ch24_Sec01_RQ10"/></para></problem></exercise>
</section>
<section class="references" id="sect-00012">
<para id="para-00029">American Addiction Centers. (2023). <emphasis effect="italics">Pseudoephedrine: Side effects, safety &amp; uses of Sudafed.</emphasis> https://americanaddictioncenters.org/over-the-counter-medications/pseudoephedrine</para>
<para id="para-00030">Cleveland Clinic. (2021). <emphasis effect="italics">Expectorant.</emphasis> https://my.clevelandclinic.org/health/drugs/22078-expectorant</para>
<para id="para-00031">Corren, J. (2017). Allergic rhinitis and conjunctivitis. <emphasis effect="italics">Middleton’s Allergy Essentials</emphasis> (pp. 205–224). Elsevier. https://doi.org/10.1016/b978-0-323-37579-5.00008-8</para>
<para id="para-00032">DailyMed. (Updated August 21, 2019). <emphasis effect="italics">Acetylcysteine inhalant.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f56b4087-db48-4fd7-84ec-9c927962b805</para>
<para id="para-00033">DailyMed. (Updated July 16, 2021). <emphasis effect="italics">Acetylcysteine injection.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4505de2a-ef6f-4bb7-9845-1228afbe0a0e</para>
<para id="para-00034">DailyMed. (Updated July 13, 2021). <emphasis effect="italics">Benzonatate capsule.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6de49806-eceb-4fc5-a90c-5d00c9025ae0</para>
<para id="para-00035">DailyMed. (Updated June 8, 2023). <emphasis effect="italics">Brompheniramine maleate, dextromethorphan hydrobromide, and phenylephrine hydrochloride elixir.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc09a8c5-d173-4261-b838-96e6a16e2ff9</para>
<para id="para-00036">DailyMed. (Updated May 19, 2023). <emphasis effect="italics">Cetirizine hydrochloride tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b165db38-b302-4220-8627-77cb07bb078c</para>
<para id="para-00037">DailyMed. (Updated March 29, 2023). <emphasis effect="italics">Chlorpheniramine maleate tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31dec627-f2e4-6dbe-e05400144ff8d46c&amp;audience=consumer</para>
<para id="para-00038">DailyMed. (Updated November 16, 2022). <emphasis effect="italics">Codeine guaifenesin solution.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe126254-6ee6-48c3-965c-96e4276a5314</para>
<para id="para-00039">DailyMed. (Updated December 14, 2010). <emphasis effect="italics">Desloratadine tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b546121-ef6b-458c-ae0c-ce5bba3dc9a3</para>
<para id="para-00040">DailyMed. (Updated November 16, 2020). <emphasis effect="italics">Dextromethorphan tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=DEXTROMETHORPHAN</para>
<para id="para-00041">DailyMed. (Updated July 14, 2022). <emphasis effect="italics">Diphenhydramine hydrochloride tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d026ead-c3de-4dc6-9d3c-5a603f6dde4e</para>
<para id="para-00042">DailyMed. (Updated October 21, 2020). <emphasis effect="italics">Dornase alfa solution.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d8c78a7e-ff99-48f3-8952-643ec2ea0f86</para>
<para id="para-00043">DailyMed. (Updated February 26, 2023). <emphasis effect="italics">Fexofenadine tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08023b99-0634-4ac9-afd6-4f2d2e0d2c8a</para>
<para id="para-00044">DailyMed. (Updated January 28, 2022). <emphasis effect="italics">Guaifenesin tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6aa1493-bc22-a318-e053-2995a90a6381</para>
<para id="para-00045">DailyMed. (Updated January 5, 2011). <emphasis effect="italics">Levocetirizine tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d416349-161d-4232-b6b4-e75214ea4841</para>
<para id="para-00046">DailyMed. (Updated December 1, 2009). <emphasis effect="italics">Loratadine tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a2f0eef-7803-497d-926c-a6163a89eb56</para>
<para id="para-00047">DailyMed. (Updated January 3, 2023). <emphasis effect="italics">Nasal decongestant D-pseudoephedrine hcl tablet, film coated.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3b5d9f7-3e4d-4b27-ac34-3192d21ee2e2</para>
<para id="para-00048">DailyMed. (Updated October 14, 2015). <emphasis effect="italics">Oxymetazoline nasal solution spray.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e1f4180-5cf8-48a0-a01f-77cd4574e2a9</para>
<para id="para-00049">DailyMed (Updated December 18, 2020). <emphasis effect="italics">Phenylephrine capsule.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a24f09d9-60f1-853a-e053-2a95a90ae1fa</para>
<para id="para-00050">DailyMed (Updated November 3, 2022). <emphasis effect="italics">Pseudoephedrine tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1056d9da-8a3f-4b7a-878e-7f8d45d298cd</para>
<para id="para-00051">Fowler, P. (2022). <emphasis effect="italics">Histamines: What they do, and how they can overreact.</emphasis> WebMD. https://www.webmd.com/allergies/what-are-histamines</para>
<para id="para-00052">Johnson and Johnson. (2023). <emphasis effect="italics">What are antihistamines and how do they work?</emphasis> ZYRTEC. https://www.zyrtec.com/allergy-guide/understanding-allergies/treatment/what-are-antihistamines</para>
<para id="para-00053">MedlinePlus. (2017). <emphasis effect="italics">Benzonatate.</emphasis> https://medlineplus.gov/druginfo/meds/a682640.html</para>
<para id="para-00054">MedlinePlus. (2018). <emphasis effect="italics">Pseudoephedrine.</emphasis> https://medlineplus.gov/druginfo/meds/a682619.html</para>
<para id="para-00055">MedlinePlus. (2022). <emphasis effect="italics">Loratadine</emphasis>. https://medlineplus.gov/druginfo/meds/a697038.html</para>
<para id="para-00056">MedlinePlus. (2023). <emphasis effect="italics">Codeine.</emphasis> https://medlineplus.gov/druginfo/meds/a682065.html</para>
<para id="para-00057">MyHealth.Alberta.ca Network. (2022). <emphasis effect="italics">Decongestants.</emphasis> https://myhealth.alberta.ca/Health/Pages/conditions.aspx?hwid=sig48021</para>
<para id="para-00058">Naqvi, A. &amp; Gerriets, V. (2023). <emphasis effect="italics">Cetirizine</emphasis>. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK549776/</para>
<para id="para-00059">NHS. (2021). <emphasis effect="italics">Fexofenadine.</emphasis> https://www.nhs.uk/medicines/fexofenadine/</para>
<para id="para-00060">Nurselabs. (2023). <emphasis effect="italics">Antitussives.</emphasis> https://nurseslabs.com/antitussives/</para>
<para id="para-00061">Ricciardi, L., Furci, F., &amp; Stefania, I. (2019). H1-antihistamines for allergic diseases: old aged but not old-fashioned drugs. <emphasis effect="italics">International Journal of Allergy Medications,</emphasis> <emphasis effect="italics">5</emphasis>, 37. doi.org/10.23937/2572-3308.1510037</para>
<para id="para-00062">Sakur, A. A., Nashed, D., &amp; Noureldin, I. (2022). Green potentiometric determination of some of the third-generation antihistamines: Fexofenadine, desloratadine, and levocetirizine by using new carbon paste electrodes. <emphasis effect="italics">Talanta Open</emphasis>, <emphasis effect="italics">5</emphasis>, 100116. https://doi.org/10.1016/j.talo.2022.100116</para>
<para id="para-00063">Sicari, V., &amp; Zabbo, C. P. (2023). <emphasis effect="italics">Diphenhydramine.</emphasis> StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK526010</para>
<para id="para-00064">Sison, G. (2022). <emphasis effect="italics">Antitussives: Uses, common brands, and safety info.</emphasis> Single Care. https://www.singlecare.com/drug-classes/antitussives</para>
</section>
</content>
<glossary>
<definition id="def-00001"><term>cystic fibrosis</term> <meaning>a genetic condition that causes mucus to be sticky and thick, leading to blockages, damage, and infections</meaning></definition>
<definition id="def-00002"><term>expectorants</term> <meaning>drugs that help to clear mucus from the airway</meaning></definition>
<definition id="def-00003"><term>Mallory-Weis tears</term> <meaning>lacerations in the esophagus or stomach that occur from prolonged vomiting or coughing; often seen in clients with alcohol misuse</meaning></definition>
<definition id="def-00004"><term>mucolytics</term> <meaning>drugs that help to clear mucus from the upper and lower airways of the respiratory system</meaning></definition>
</glossary>
</document>